Robert Cunningham - 13 May 2020 Form 4 Insider Report for AXIM BIOTECHNOLOGIES, INC. (AXIM)

Role: Director
Signature: /s/ Robert Cunningham
Issuer symbol: AXIM
Transactions as of: 13 May 2020
Net transactions value: $0
Form type: 4
Filing time: 23 Sep 2022, 16:27:28 UTC
Next filing: 23 Sep 2022
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	AXIM	Option	Award	$0	+500,000		$0.000000	500,000	13 May 2020	Common Stock	500,000	$0.0126	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Reporting Person acquired the option to purchase 500,000 shares of Issuer's common stock ("Option Shares") on May 13, 2020 (the "Date of Grant"). One-third of the Option Shares will vest on the Date of Grant; (iii) one-third of the Option Shares will vest six (6) months from the Date of Grant; and (iv) the remaining one-third of the Option Shares shall vest twelve (12) Months from the Date of Grant, provided, however, that there has not been a Termination of Service as of such date. In no event shall the Option become exercisable for any additional Option Shares after a Termination of Service.

Content

Reporting Person acquired the option to purchase 500,000 shares of Issuer's common stock ("Option Shares") on May 13, 2020 (the "Date of Grant"). One-third of the Option Shares will vest on the Date of Grant; (iii) one-third of the Option Shares will vest six (6) months from the Date of Grant; and (iv) the remaining one-third of the Option Shares shall vest twelve (12) Months from the Date of Grant, provided, however, that there has not been a Termination of Service as of such date. In no event shall the Option become exercisable for any additional Option Shares after a Termination of Service.